Carbidopa And Levodopa Tablet, Extended Release
Product Images NDC 51079-978

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 51079-978). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbidopa And Levodopa Er 25 mg/100 mg Tablets Unit Carton Label (Image 01)

This is a description of a medication named Carbidopa and Levodopa in extended-release tablets, USP @ 50 mg/200 mg. It comes in a package of 100 tablets (10 x 10). Each tablet contains Carbidopa, USP omg" and Levodopa, USP 200mg. The usual adult dosage can be found in the accompanying prescribing information and the tablets should be swallowed whole. The medication should be stored at 20° 0 25°C (68° to 77°F), protected from light. The manufacturer is Mylan Pharmaceuticals Inc. located in Morgantown, WY 26505 USA.*

FDA Label Image

Carbidopa And Levodopa Er 50 mg/200 mg Tablets Unit Carton Label (Image 02)

This unit dose package is not child resistant and is intended for institutional use only. It is important to keep this and all drugs out of the reach of children and to note that the container provides light-resistance. Information about the lot number and expiration date can be found on the window of the container. The package contains medication from the Mylan® S v brand and originates from Rockford, IL in the USA.*

FDA Label Image

Unit Carton (Image 03)

FDA Label Image

Unit Carton (Image 04)

FDA Label Image

Image 05

This is a description of a medication with the NDC code 51079-978-20. The medication is in the form of extended-release tablets containing 25mg of Carbidopa (USP) and 100mg of Levodopa (USP). The tablet is used by adults and should be swallowed without chewing or crushing. The medication should be stored at a temperature of 20°C to 25°C and protected from light. The manufacturer of the medication is Hylan Pharmaceuticals Inc, located in Morgantown, West Virginia.*

FDA Label Image

Image 06

This unit dose package is not child resistant and is intended for institutional use only. It is advised to keep this and all drugs out of the reach of children. The container provides light resistance and contains Mylan® S v medication. The window on the container displays the lot number and expiration date. The manufacturer is located in Rockford, Illinois in the United States.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.